JP2005520824A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005520824A5 JP2005520824A5 JP2003575973A JP2003575973A JP2005520824A5 JP 2005520824 A5 JP2005520824 A5 JP 2005520824A5 JP 2003575973 A JP2003575973 A JP 2003575973A JP 2003575973 A JP2003575973 A JP 2003575973A JP 2005520824 A5 JP2005520824 A5 JP 2005520824A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- present
- compound
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 3
- PUSNGFYSTWMJSK-GSZQVNRLSA-N (2R,3R,4S,5R,6R)-2,3,4-trimethoxy-6-(methoxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[(2R,3R,4S,5R,6S)-3,4,5-tris(2-hydroxypropoxy)-6-[(2R,3R,4S,5R,6R)-4,5,6-tris(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)oxan- Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](OC)O[C@@H]1COC.CC(O)CO[C@@H]1[C@@H](OCC(C)O)[C@H](OCC(C)O)[C@@H](COCC(O)C)O[C@H]1O[C@H]1[C@H](OCC(C)O)[C@@H](OCC(C)O)[C@H](OCC(C)O)O[C@@H]1COCC(C)O PUSNGFYSTWMJSK-GSZQVNRLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 239000004677 Nylon Substances 0.000 claims 1
- 102100015381 PTGS2 Human genes 0.000 claims 1
- 101710040930 PTGS2 Proteins 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001404 mediated Effects 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 229920001778 nylon Polymers 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 230000001575 pathological Effects 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 238000001238 wet grinding Methods 0.000 claims 1
Claims (6)
- １以上の医薬的に許容される担体または賦形剤と混合されて、化合物(I)
- さらに、15重量%未満の量で存在するHPMCを含んでいる、請求項１に記載の医薬組成物。
- さらに、30〜45重量%の量で存在するマンニトールを含んでいる、請求項１または２に記載の医薬組成物。
- さらに、約0.6重量%の量で存在するラウリル硫酸ナトリウムを含んでいる、請求項１〜３のいずれか１項に記載の医薬組成物。
- 少なくとも１つのチャンバーおよび撹拌手段を有しているミル中で化合物(I)の懸濁液を湿式ミリングすることを含んでなる、請求項１〜４のいずれか１項に記載の医薬組成物の調製方法において、該チャンバーおよび／または該撹拌手段が潤滑剤入りナイロンを含んでいる上記方法。
- COX-2が介在する病態の治療用医薬の製造のための、請求項１〜４のいずれか１項に記載の医薬組成物の使用。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0206200.8A GB0206200D0 (en) | 2002-03-15 | 2002-03-15 | Pharmaceutical compositions |
| PCT/EP2003/002698 WO2003077920A1 (en) | 2002-03-15 | 2003-03-13 | Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo’1,5-bipyridazine in nanoparticulate form |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005520824A JP2005520824A (ja) | 2005-07-14 |
| JP2005520824A5 true JP2005520824A5 (ja) | 2006-01-05 |
Family
ID=9933079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003575973A Pending JP2005520824A (ja) | 2002-03-15 | 2003-03-13 | ナノ粒子形態の２−（４−エトキシ−フェニル）−３−（４−メタンスルホニル−フェニル）−ピラゾロ［１，５−ｂ］ピリダジンを含有する医薬組成物 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20050153967A1 (ja) |
| EP (1) | EP1485098B1 (ja) |
| JP (1) | JP2005520824A (ja) |
| KR (1) | KR20040091133A (ja) |
| CN (1) | CN1642549A (ja) |
| AT (1) | ATE350038T1 (ja) |
| AU (1) | AU2003208709A1 (ja) |
| BR (1) | BR0307427A (ja) |
| CA (1) | CA2478758A1 (ja) |
| DE (1) | DE60310896T2 (ja) |
| EA (1) | EA007201B1 (ja) |
| EC (1) | ECSP045295A (ja) |
| ES (1) | ES2277634T3 (ja) |
| GB (2) | GB0206200D0 (ja) |
| IS (1) | IS7378A (ja) |
| MX (1) | MXPA04009008A (ja) |
| NO (1) | NO20043889L (ja) |
| NZ (1) | NZ534179A (ja) |
| PL (1) | PL372932A1 (ja) |
| WO (1) | WO2003077920A1 (ja) |
| ZA (1) | ZA200406553B (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006500372A (ja) | 2002-08-19 | 2006-01-05 | グラクソ グループ リミテッド | 選択的ｃｏｘ−２阻害物質としてのピリミジン誘導体 |
| GB0221443D0 (en) | 2002-09-16 | 2002-10-23 | Glaxo Group Ltd | Pyridine derivates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| EP1510519B1 (en) * | 1997-09-05 | 2006-02-15 | Glaxo Group Limited | Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives |
| AU784490B2 (en) * | 1999-12-08 | 2006-04-13 | Pharmacia Corporation | Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| CA2413330A1 (en) * | 2000-06-28 | 2002-01-03 | Smithkline Beecham P.L.C. | Wet milling process |
-
2002
- 2002-03-15 GB GBGB0206200.8A patent/GB0206200D0/en not_active Ceased
-
2003
- 2003-03-13 MX MXPA04009008A patent/MXPA04009008A/es not_active Application Discontinuation
- 2003-03-13 CN CNA038061058A patent/CN1642549A/zh active Pending
- 2003-03-13 AU AU2003208709A patent/AU2003208709A1/en not_active Abandoned
- 2003-03-13 EP EP03706615A patent/EP1485098B1/en not_active Expired - Lifetime
- 2003-03-13 ES ES03706615T patent/ES2277634T3/es not_active Expired - Lifetime
- 2003-03-13 BR BR0307427-7A patent/BR0307427A/pt not_active IP Right Cessation
- 2003-03-13 NZ NZ534179A patent/NZ534179A/en unknown
- 2003-03-13 EA EA200400864A patent/EA007201B1/ru not_active IP Right Cessation
- 2003-03-13 DE DE60310896T patent/DE60310896T2/de not_active Expired - Fee Related
- 2003-03-13 WO PCT/EP2003/002698 patent/WO2003077920A1/en active IP Right Grant
- 2003-03-13 US US10/506,934 patent/US20050153967A1/en not_active Abandoned
- 2003-03-13 CA CA002478758A patent/CA2478758A1/en not_active Abandoned
- 2003-03-13 AT AT03706615T patent/ATE350038T1/de not_active IP Right Cessation
- 2003-03-13 JP JP2003575973A patent/JP2005520824A/ja active Pending
- 2003-03-13 PL PL03372932A patent/PL372932A1/xx not_active Application Discontinuation
- 2003-03-13 KR KR10-2004-7014357A patent/KR20040091133A/ko not_active Application Discontinuation
- 2003-03-13 GB GB0419971A patent/GB2402335B/en not_active Expired - Fee Related
-
2004
- 2004-07-29 IS IS7378A patent/IS7378A/is unknown
- 2004-08-17 ZA ZA200406553A patent/ZA200406553B/en unknown
- 2004-09-14 EC EC2004005295A patent/ECSP045295A/es unknown
- 2004-09-16 NO NO20043889A patent/NO20043889L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1170542C (zh) | 奥卡西平包膜片剂 | |
| WO2002020466B1 (en) | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents | |
| JP2006506357A (ja) | 有機高分子物質との組み合わせで無機粒子を含み、かつ固体の網目状マトリックスを形成する医薬賦形剤、その組成物、製造および使用 | |
| JP2006506357A6 (ja) | 有機高分子物質との組み合わせで無機粒子を含み、かつ固体の網目状マトリックスを形成する医薬賦形剤、その組成物、製造および使用 | |
| AU2015243103A1 (en) | Dosing regimen associated with long-acting injectable paliperidone esters | |
| EP2813511A3 (en) | Ferric organic compounds, uses thereof and methods of making same | |
| JP2005537268A5 (ja) | ||
| JP2010513363A5 (ja) | ||
| JP2009501202A5 (ja) | ||
| CN1189098A (zh) | 用碱性试剂稳定的药物组合物 | |
| NZ620887A (en) | A novel formulation of diclofenac | |
| JP2007537301A5 (ja) | ||
| EP1039913A1 (fr) | Comprime de progesterone et son procede de preparation | |
| AU2002350082B2 (en) | Process for preparing quick dissolving, high loading ribavirin compositions | |
| JP2008521932A5 (ja) | ||
| JP2015524444A5 (ja) | ||
| JP2006512324A5 (ja) | ||
| CN1954814A (zh) | 一种具有协同作用治疗痛风的药物组合物及其制备方法 | |
| KR20170134583A (ko) | 장기간 작용형 주사용 팔리페리돈 에스테르에 대한 누락된 용량에 대한 투여 계획 | |
| JP2006514100A5 (ja) | ||
| JP2000514059A (ja) | トリアゾール抗真菌化合物を含む経口組成物 | |
| US8309138B2 (en) | Pharmaceutical composition comprising microparticle oily suspension | |
| BR0307278A (pt) | Formulação oral de liberação imediata, e, método para preparar uma formulação | |
| JPH0769874A (ja) | カプセル形態のユビデカレノン経口製剤 | |
| CN1105361A (zh) | 抑制血管生成和血管原性疾病的方法 |